pSEVA421-Cas9tr
(Plasmid
#138709)
-
PurposePlasmid constitutively expressing the Cas9 nuclease and the non-coding tracrRNA from S. pyogenes
-
Depositing Lab
-
Sequence Information
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 138709 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backbonepSEVA421
-
Backbone manufacturerStandard European Vector Architecture
- Backbone size w/o insert (bp) 3882
- Total vector size (bp) 8506
-
Modifications to backbonetracrRNA-Cas9 was PCR amplified from pCas9 (Jiang et al, Nat Biotechnol 2013, 31, 233-239) and the 4.7 Kb fragment was cloned by Gibson Assembly in pSEVA421 restricted with SanDI/SwaI
-
Vector typeBacterial Expression, CRISPR, Synthetic Biology
Growth in Bacteria
-
Bacterial Resistance(s)Spectinomycin and Streptomycin, 50 & 50 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)DH5alpha
-
Copy numberLow Copy
Gene/Insert
-
Gene/Insert nametracrRNA-Cas9
-
SpeciesStreptococcus pyogenes
-
Insert Size (bp)4644
Cloning Information
- Cloning method Gibson Cloning
- 5′ sequencing primer gaacgctcggttgccgc
- 3′ sequencing primer ctgcgtaacatcgttgctgctcca (Common Sequencing Primers)
Resource Information
-
A portion of this plasmid was derived from a plasmid made byAparicio T, de Lorenzo V, Martínez-García E (2018) CRISPR/Cas9-based counterselection boosts recombineering efficiency in Pseudomonas putida. Biotechnol J 13(5):1700161
-
Article Citing this Plasmid
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
pSEVA421-Cas9tr was a gift from Víctor de Lorenzo (Addgene plasmid # 138709 ; http://n2t.net/addgene:138709 ; RRID:Addgene_138709) -
For your References section:
Recombination-Independent Genome Editing through CRISPR/Cas9-Enhanced TargeTron Delivery. Velazquez E, Lorenzo V, Al-Ramahi Y. ACS Synth Biol. 2019 Sep 20;8(9):2186-2193. doi: 10.1021/acssynbio.9b00293. Epub 2019 Sep 3. 10.1021/acssynbio.9b00293 PubMed 31419111